A Clinical Trial of Decitabine in Patients With Myelodysplastic Syndrome
Status:
Terminated
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to determine which of the doses of decitabine maximizes genomic
demethylation in patients with Myelodysplastic Syndrome (MDS).